Unmet Needs and Restraints: Overcoming Challenges in Xerosis Treatment
Despite the positive growth trajectory, the Xerosis Market faces several restraints and addresses persistent unmet needs that challenge its maximum potential of $5.2 Billion. The primary clinical challenge is the lack of a definitive cure and the chronic, progressive nature of the condition, requiring lifelong adherence to often-inconvenient topical regimens. Patient compliance can be poor,...
0 Kommentare 0 Geteilt 550 Ansichten 0 Bewertungen
Gesponsert